VAERS 2587120
MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u004714
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 24.02.2023
- Impfdatum
- -
- Beginn
- 22.02.2023
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / -
Symptomtext
No additional adverse event; Nurse reported that a patient received an expired VARVIVAX.; This spontaneous report was received from a nurse referring to a unknown age and gender patient. No information regarding the patient's medical history, concurrent conditions, previous drug reactions or allergies and concomitant medications was provided. On 22-FEB-2023, the patient was vaccinated with an expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 1 dose, lot #u004714, expiration date: 10-FEB-2023 (who had been verified to be a valid number and assessed as the same date reported) administered for prophylaxis (strength, dose, and route of administration were not provided) (expired product administered). No additional adverse event reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -